Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 126Breast Neoplasms 78Neoplasms 48Prostatic Neoplasms 19Fatigue 16Obesity 14Colorectal Neoplasms 13Lung Neoplasms 11Polycystic Ovary Syndrome 10Colonic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Weight Loss 6Ovarian Neoplasms 6Rectal Neoplasms 5Multiple Myeloma 5Lymphedema 5Leukemia 5Inflammation 5Pancreatic Neoplasms 4Overweight 4Multiple Endocrine Neoplasia Type 1 4Lymphoma 4Leukemia, Myeloid, Acute 4Insulin Resistance 4Depression 4Cognitive Dysfunction 4Brain Neoplasms 4Stomach Neoplasms 3Peripheral Nervous System Diseases 3

Interventions

veliparib 1tipifarnib 1Mitozytrex 1Mitomycin 1Immunoglobulin G 1Exercise 1Erlotinib Hydrochloride 1Disulfides 1Bevacizumab 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Solid Neoplasm × Exercise × Clear all
NCT03098277 2025-06-25

Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy

University of Southern California

Phase NA Completed
41 enrolled

Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡